CGS Chief Medical Officer is Hosting a Meeting on the New Cellular Tissue Product / Skin Substitute LCD on December 20th

December 16, 2024

Join the CGS Chief Medical Officer on Friday, December 20, 2024, from 10:00AM to 11:00AM Eastern Time to review the following LCD and articles:

LCD – Skin Substitute Grafts/Cellular and Tissue-Based Products for the Treatment of Diabetic Foot Ulcers and Venous Leg Ulcers (L39756)
Article – Billing and Coding: Skin Substitutes Grafts/Cellular and Tissue-Based Products for the Treatment of Diabetic Foot Ulcers and Venous Leg Ulcers (A59618)
Article – Response to Comments: Skin Substitute Grafts/Cellular and Tissue-Based Products for the Treatment of Diabetic Foot Ulcers and Venous Leg Ulcers (A59941)

Registration is required:

Pre-submitted questions can be sent to: J15MRPolicy@cgsadmin.com

Dr. Fife is Co-Founder and Chief Medical Officer of Intellicure, Executive Director of the US Wound Registry, and Editor of Today’s Wound Clinic.

Submit the form below to receive email alerts when Intellicure publishes a new blog post! This information will not be shared.

The New LCDs are (Almost Certainly) Coming to Town

Dec 19, 2024

I may post more information about the meeting later, but the general tone of the MAC medical directors was confident.

Dec 10, 2024

The American Medical Association (AMA) and the Illinois State Medical Society (ISMS) have filed a lawsuit in federal court.

Dec 5, 2024

The sad news is that CMS is going ahead with a 2.9% cut to Medicare physician reimbursements for 2025.